Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kayla Landrum"'
Autor:
Bita Sahaf, Sreevidya Kurra, Michelle Fujimoto, Anne Cunniffe Marcy, Crystal L. Mackall, Emily Egeler, Gerald A. Grant, Angus Toland, Kayla Landrum, John S. Tamaresis, Sneha Ramakrishna, Rebecca Richards, Paul G. Fisher, Kara L. Davis, Courtney Erickson, Steven A. Feldman, Sharon Mavroukakis, Michael Kunicki, Michelle Monje, Timothy T. Cornell, Sonia Partap, Agnes Reschke, Lindsay Rasmussen, Jasia Mahdi, Valentin Barsan, Hannes Vogel, Robbie G. Majzner, Cynthia J. Campen, Jennifer Moon, Zach Ehlinger, Christina Baggott, Kristen W. Yeom, Liora M. Schultz, Harshini Chinnasamy, Shabnum Patel, Aaron Mochizuki
Publikováno v:
Neuro-Oncology
Background We previously discovered high expression of the disialoganglioside GD2 on H3K27M+ gliomas and demonstrated preclinical efficacy of intravenous (IV) GD2-targeted chimeric antigen receptor (CAR) T-cells in preclinical models of H3K27M-mutate
Autor:
Steven A. Feldman, Courtney Erickson, Sharon Mavroukakis, Kara L. Davis, Anne Cunniffe Marcy, Rebecca Richards, Emily Egeler, Zach Ehlinger, Crystal L. Mackall, Kristen W. Yeom, Angus Toland, Bita Sahaf, Agnes Reschke, Michael Kunicki, Michelle Fujimoto, Gerald A. Grant, Aaron Mochizuki, Liora M. Schultz, Harshini Chinnasamy, Shabnum Patel, John S. Tamaresis, Michelle Monje, Lindsey Rasmussen, Christina Baggott, Paul G. Fisher, Jennifer Moon, Cynthia J. Campen, Kayla Landrum, Hannes Vogel, Robbie G. Majzner, Sneha Ramakrishna, Sreevidya Kurra, Valentin Barsan, Sonia Partap, Timothy T. Cornell, Jasia Mahdi
Publikováno v:
Cancer Research. 81:CT031-CT031
Background: Diffuse intrinsic pontine glioma (DIPG) and other H3K27M-mutated diffuse midline gliomas (DMGs) are universally lethal central nervous system tumors. We previously discovered that the disialoganglioside GD2 is highly and homogenously expr
Autor:
Courtney Erickson, Sharon Mavroukakis, Lindsey Rasmussen, Emily Egeler, Rebecca Richards, Sonia Partap, John S. Tamaresis, Aaron Mochizuki, Anne Cunniffe Marcy, Kristen W. Yeom, Jennifer Moon, Harshini Chinnasamy, Steven A. Feldman, Gerald A. Grant, Zach Ehlinger, Crystal L. Mackall, Agnes Reschke, Christina Baggot, Paul G. Fisher, Liora M. Schultz, Shabnum Patel, Kayla Landrum, Zina Good, Michelle Monje, Cynthia J. Campen, Michael Kunicki, Michelle Celones, Timothy T. Cornell, Jasia Mahdi, Sreevidya Kurra, Hannes Vogel, Robbie G. Majzner, Valentin Barsan, Kara L. Davis, Bita Sahaf, Angus Toland, Sneha Ramakrishna
Publikováno v:
Neuro-Oncology
Introduction We are conducting a Phase I clinical trial utilizing chimeric antigen receptor (CAR) T-cells targeting GD2 (NCT04196413) for H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) and spinal cord diffuse midline glioma (DMG). Cerebrospina